FDA

After a fairly slow 2016, the United States Food and Drug Administration’s (FDA) Office of Prescription Drug Promotion (OPDP)…

In January, FDA’s Center for Drug Evaluation and Research (CDER) released its annual guidance agenda, announcing the new and…

In a last-minute attempt to put a permanent mark on the life sciences (and specifically, the medical device) industry, the…

The United States Food and Drug Administration (FDA) offers a podcast series, known as the Director’s Corner, that features the…

On one of his first few days on the job, President Donald Trump signed an executive order that would require all government…

In November, the FDA held a two-day Town Hall meeting to allow for input from stakeholders and patients surrounding…

A few months back, the U.S. Food and Drug Administration and the Centers for Medicare & Medicaid Services announced they are…

On February 8, 2017, three organizations called on the United States Food and Drug Administration (FDA) to overhaul a newly…

Recently, the Food and Drug Administration (FDA) finalized guidance detailing its approach to assigning non-proprietary names to…

As reported by Regulatory Focus, the FDA announced the “safety labeling changes” (SLC) program. It will be reportedly…